Synthetic analogs of sphingolipids
US8962891B2 · kind B2 · utility
0Cited by
14References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 9, 2008 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | Sep 23, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides new ceramide analogs indicated as the compounds of formula (II). These novel analogs exhibit a significant anti cancerous effect and are therefore provided as a pharmaceutical composition for treating cell proliferative diseases, neurodegenerative disorders, metabolism-associated conditions, infectious diseases, and immune-related disorders. The invention further provides combined compositions and kits combining the novel ceramide analogs of formula (II) with an additional therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.